Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-19

FDA Approved: TAFLUPROST — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved Micro Labs Limited's tafluprost ophthalmic solution as an Original Application (generic) product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tafluprost (tafluprost)

Snippet

ORIG AP for TAFLUPROST (TAFLUPROST OPTHALMIC)